Home > Balance Sheet > AUROBINDO PHARMA

AUROBINDO PHARMA
Net Current Assets

    Back to Balance Sheet
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Net Current Assets History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Current Assets (Including Current Investments) ₹11,573 Cr₹9,966 Cr₹9,888 Cr₹9,075 Cr₹5,028 Cr

What is the latest Net Current Assets ratio of AUROBINDO PHARMA ?

The latest Net Current Assets ratio of AUROBINDO PHARMA is ₹11,573 Cr based on Mar2024 Consolidated results.
Year Net Current Assets
Mar2024₹11,573 Cr
Mar2023₹9,966 Cr
Mar2022₹9,888 Cr
Mar2021₹9,075 Cr
Mar2020₹5,028 Cr

How is Net Current Assets of AUROBINDO PHARMA Trending?

Years Net Current Assets % Change
Mar2024 ₹11,573 Cr
16.12
Mar2023 ₹9,966 Cr
0.79
Mar2022 ₹9,888 Cr
8.96
Mar2021 ₹9,075 Cr
80.49
Mar2020 ₹5,028 Cr -

Compare Net Current Assets of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹64,439.8 Cr -4.4% -8% -8.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹395,614.0 Cr -2.5% -4.7% 11.9% Stock Analytics
DIVIS LABORATORIES ₹173,533.0 Cr -2.7% -0.7% 50.4% Stock Analytics
CIPLA ₹121,439.0 Cr -1.2% 0.8% -0.9% Stock Analytics
DR REDDYS LABORATORIES ₹110,076.0 Cr -2.3% 8.2% 11.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,066.0 Cr 1.4% -1.5% 13.3% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-4.4%

-8%

-8.3%

SENSEX

-1%

-0.9%

6.7%


You may also like the below Video Courses